Cardiol Therapeutics Inc.

NASDAQ:CRDL

1.83 (USD) • At close October 29, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -0.028-30.931-31.638-20.641-13.684-15.894-1.661
Depreciation & Amortization 00.220.220.230.1510.0910.053
Deferred Income Tax 0-9.161-4.916007.8820
Stock Based Compensation 0.0045.0138.4982.7653.2661.6530
Change In Working Capital 0.0015.7480.0778.316-1.621-5.2020.048
Accounts Receivables 0-0.144-0.060.708-0.467-0.359-0.102
Inventory 0-4.4750.0181.1010.143-0.0060
Accounts Payables -1.2934.4752.393-0.7080.4671.9650.177
Other Working Capital 0.0015.892-2.2757.215-1.763-7.167-0.128
Other Non Cash Items -0.0021.894.2090.1450.5080.5750.267
Operating Cash Flow -0.025-27.22-23.551-9.185-11.38-10.894-1.292
Investing Activities:
Investments In Property Plant And Equipment -0-0.075-0.013-0.041-0.424-0.014-0.029
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 000000-0.007
Investing Cash Flow -0-0.075-0.013-0.041-0.424-0.014-0.029
Financing Activities:
Debt Repayment -0-0.054-0.052-0.05-0.02-12.069-0.4
Common Stock Issued 0084.08417.251.66714.2343.398
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 009.406-0.9050.38211.0490.279
Financing Cash Flow -0-0.05493.43816.2952.02925.2833.678
Other Information:
Effect Of Forex Changes On Cash 0.0012.92-0.011-0.056000
Net Change In Cash -0.025-24.42969.8747.069-9.77514.3752.357
Cash At End Of Period 0.03559.4783.89914.0256.95616.7322.357